The global Obesity Treatment market size was estimated at USD 5452.10 million in 2023 and is projected to reach USD 16907.57 million by 2032, exhibiting a CAGR of 13.40% during the forecast period.
North America Obesity Treatment market size was estimated at USD 1765.75 million in 2023, at a CAGR of 11.49% during the forecast period of 2025 through 2032.
Report Overview
Obesity is a major health problem worldwide responsible for increased morbidity/mortality and high cost for the society. Management of obesity requires multidisciplinary approaches including diet, food supplement, exercise, behavior change, drug, medical device, gut microbiome manipulation, and surgery. Anti-obesity medical devices are an option for subjects who have not responded to more conservative medical treatments but want an alternative to surgery.
This report provides a deep insight into the global Obesity Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Obesity Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Obesity Treatment market in any manner.
Global Obesity Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- NutriSystem
- Inc. (U.S.)
- Kellogg Company (U.S.)
- Ethicon
- Inc. (U.S.)
- Medtronic (U.S.)
- F. Hoffmann-La Roche (Switzerland)
- Atkins Nutritionals
- Inc. (U.S.)
- Herbalife Ltd. (U.S.)
- Covidien plc (U.S.)
- Apollo Endosurgery (U.S.)
- Amer Sports (Finland)
- Johnson Health Technology
- Ltd. (Taiwan)
- Cybex International (U.S.)
- USGI Medical (U.S.)
- Olympus Corporation (Japan)
- Brunswick Corporation (U.S.)
- Technogym SpA (Italy)
Market Segmentation (by Type)
- Surgical & Implant Devices
- Medication Therapy
- Dietary
- Other
Market Segmentation (by Application)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Obesity Treatment Market
- Overview of the regional outlook of the Obesity Treatment Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Obesity Treatment
1.2 Key Market Segments
1.2.1 Obesity Treatment Segment by Type
1.2.2 Obesity Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Obesity Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Obesity Treatment Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Obesity Treatment Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Obesity Treatment Market Competitive Landscape
3.1 Global Obesity Treatment Sales by Manufacturers (2019-2025)
3.2 Global Obesity Treatment Revenue Market Share by Manufacturers (2019-2025)
3.3 Obesity Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Obesity Treatment Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Obesity Treatment Sales Sites, Area Served, Product Type
3.6 Obesity Treatment Market Competitive Situation and Trends
3.6.1 Obesity Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Obesity Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Obesity Treatment Industry Chain Analysis
4.1 Obesity Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Obesity Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Obesity Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Obesity Treatment Sales Market Share by Type (2019-2025)
6.3 Global Obesity Treatment Market Size Market Share by Type (2019-2025)
6.4 Global Obesity Treatment Price by Type (2019-2025)
7 Obesity Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Obesity Treatment Market Sales by Application (2019-2025)
7.3 Global Obesity Treatment Market Size (M USD) by Application (2019-2025)
7.4 Global Obesity Treatment Sales Growth Rate by Application (2019-2025)
8 Obesity Treatment Market Consumption by Region
8.1 Global Obesity Treatment Sales by Region
8.1.1 Global Obesity Treatment Sales by Region
8.1.2 Global Obesity Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Obesity Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Obesity Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Obesity Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Obesity Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Obesity Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Obesity Treatment Market Production by Region
9.1 Global Production of Obesity Treatment by Region (2019-2025)
9.2 Global Obesity Treatment Revenue Market Share by Region (2019-2025)
9.3 Global Obesity Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Obesity Treatment Production
9.4.1 North America Obesity Treatment Production Growth Rate (2019-2025)
9.4.2 North America Obesity Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Obesity Treatment Production
9.5.1 Europe Obesity Treatment Production Growth Rate (2019-2025)
9.5.2 Europe Obesity Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Obesity Treatment Production (2019-2025)
9.6.1 Japan Obesity Treatment Production Growth Rate (2019-2025)
9.6.2 Japan Obesity Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Obesity Treatment Production (2019-2025)
9.7.1 China Obesity Treatment Production Growth Rate (2019-2025)
9.7.2 China Obesity Treatment Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 NutriSystem
10.1.1 NutriSystem Obesity Treatment Basic Information
10.1.2 NutriSystem Obesity Treatment Product Overview
10.1.3 NutriSystem Obesity Treatment Product Market Performance
10.1.4 NutriSystem Business Overview
10.1.5 NutriSystem Obesity Treatment SWOT Analysis
10.1.6 NutriSystem Recent Developments
10.2 Inc. (U.S.)
10.2.1 Inc. (U.S.) Obesity Treatment Basic Information
10.2.2 Inc. (U.S.) Obesity Treatment Product Overview
10.2.3 Inc. (U.S.) Obesity Treatment Product Market Performance
10.2.4 Inc. (U.S.) Business Overview
10.2.5 Inc. (U.S.) Obesity Treatment SWOT Analysis
10.2.6 Inc. (U.S.) Recent Developments
10.3 Kellogg Company (U.S.)
10.3.1 Kellogg Company (U.S.) Obesity Treatment Basic Information
10.3.2 Kellogg Company (U.S.) Obesity Treatment Product Overview
10.3.3 Kellogg Company (U.S.) Obesity Treatment Product Market Performance
10.3.4 Kellogg Company (U.S.) Obesity Treatment SWOT Analysis
10.3.5 Kellogg Company (U.S.) Business Overview
10.3.6 Kellogg Company (U.S.) Recent Developments
10.4 Ethicon
10.4.1 Ethicon Obesity Treatment Basic Information
10.4.2 Ethicon Obesity Treatment Product Overview
10.4.3 Ethicon Obesity Treatment Product Market Performance
10.4.4 Ethicon Business Overview
10.4.5 Ethicon Recent Developments
10.5 Inc. (U.S.)
10.5.1 Inc. (U.S.) Obesity Treatment Basic Information
10.5.2 Inc. (U.S.) Obesity Treatment Product Overview
10.5.3 Inc. (U.S.) Obesity Treatment Product Market Performance
10.5.4 Inc. (U.S.) Business Overview
10.5.5 Inc. (U.S.) Recent Developments
10.6 Medtronic (U.S.)
10.6.1 Medtronic (U.S.) Obesity Treatment Basic Information
10.6.2 Medtronic (U.S.) Obesity Treatment Product Overview
10.6.3 Medtronic (U.S.) Obesity Treatment Product Market Performance
10.6.4 Medtronic (U.S.) Business Overview
10.6.5 Medtronic (U.S.) Recent Developments
10.7 F. Hoffmann-La Roche (Switzerland)
10.7.1 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Basic Information
10.7.2 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product Overview
10.7.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product Market Performance
10.7.4 F. Hoffmann-La Roche (Switzerland) Business Overview
10.7.5 F. Hoffmann-La Roche (Switzerland) Recent Developments
10.8 Atkins Nutritionals
10.8.1 Atkins Nutritionals Obesity Treatment Basic Information
10.8.2 Atkins Nutritionals Obesity Treatment Product Overview
10.8.3 Atkins Nutritionals Obesity Treatment Product Market Performance
10.8.4 Atkins Nutritionals Business Overview
10.8.5 Atkins Nutritionals Recent Developments
10.9 Inc. (U.S.)
10.9.1 Inc. (U.S.) Obesity Treatment Basic Information
10.9.2 Inc. (U.S.) Obesity Treatment Product Overview
10.9.3 Inc. (U.S.) Obesity Treatment Product Market Performance
10.9.4 Inc. (U.S.) Business Overview
10.9.5 Inc. (U.S.) Recent Developments
10.10 Herbalife Ltd. (U.S.)
10.10.1 Herbalife Ltd. (U.S.) Obesity Treatment Basic Information
10.10.2 Herbalife Ltd. (U.S.) Obesity Treatment Product Overview
10.10.3 Herbalife Ltd. (U.S.) Obesity Treatment Product Market Performance
10.10.4 Herbalife Ltd. (U.S.) Business Overview
10.10.5 Herbalife Ltd. (U.S.) Recent Developments
10.11 Covidien plc (U.S.)
10.11.1 Covidien plc (U.S.) Obesity Treatment Basic Information
10.11.2 Covidien plc (U.S.) Obesity Treatment Product Overview
10.11.3 Covidien plc (U.S.) Obesity Treatment Product Market Performance
10.11.4 Covidien plc (U.S.) Business Overview
10.11.5 Covidien plc (U.S.) Recent Developments
10.12 Apollo Endosurgery (U.S.)
10.12.1 Apollo Endosurgery (U.S.) Obesity Treatment Basic Information
10.12.2 Apollo Endosurgery (U.S.) Obesity Treatment Product Overview
10.12.3 Apollo Endosurgery (U.S.) Obesity Treatment Product Market Performance
10.12.4 Apollo Endosurgery (U.S.) Business Overview
10.12.5 Apollo Endosurgery (U.S.) Recent Developments
10.13 Amer Sports (Finland)
10.13.1 Amer Sports (Finland) Obesity Treatment Basic Information
10.13.2 Amer Sports (Finland) Obesity Treatment Product Overview
10.13.3 Amer Sports (Finland) Obesity Treatment Product Market Performance
10.13.4 Amer Sports (Finland) Business Overview
10.13.5 Amer Sports (Finland) Recent Developments
10.14 Johnson Health Technology
10.14.1 Johnson Health Technology Obesity Treatment Basic Information
10.14.2 Johnson Health Technology Obesity Treatment Product Overview
10.14.3 Johnson Health Technology Obesity Treatment Product Market Performance
10.14.4 Johnson Health Technology Business Overview
10.14.5 Johnson Health Technology Recent Developments
10.15 Ltd. (Taiwan)
10.15.1 Ltd. (Taiwan) Obesity Treatment Basic Information
10.15.2 Ltd. (Taiwan) Obesity Treatment Product Overview
10.15.3 Ltd. (Taiwan) Obesity Treatment Product Market Performance
10.15.4 Ltd. (Taiwan) Business Overview
10.15.5 Ltd. (Taiwan) Recent Developments
10.16 Cybex International (U.S.)
10.16.1 Cybex International (U.S.) Obesity Treatment Basic Information
10.16.2 Cybex International (U.S.) Obesity Treatment Product Overview
10.16.3 Cybex International (U.S.) Obesity Treatment Product Market Performance
10.16.4 Cybex International (U.S.) Business Overview
10.16.5 Cybex International (U.S.) Recent Developments
10.17 USGI Medical (U.S.)
10.17.1 USGI Medical (U.S.) Obesity Treatment Basic Information
10.17.2 USGI Medical (U.S.) Obesity Treatment Product Overview
10.17.3 USGI Medical (U.S.) Obesity Treatment Product Market Performance
10.17.4 USGI Medical (U.S.) Business Overview
10.17.5 USGI Medical (U.S.) Recent Developments
10.18 Olympus Corporation (Japan)
10.18.1 Olympus Corporation (Japan) Obesity Treatment Basic Information
10.18.2 Olympus Corporation (Japan) Obesity Treatment Product Overview
10.18.3 Olympus Corporation (Japan) Obesity Treatment Product Market Performance
10.18.4 Olympus Corporation (Japan) Business Overview
10.18.5 Olympus Corporation (Japan) Recent Developments
10.19 Brunswick Corporation (U.S.)
10.19.1 Brunswick Corporation (U.S.) Obesity Treatment Basic Information
10.19.2 Brunswick Corporation (U.S.) Obesity Treatment Product Overview
10.19.3 Brunswick Corporation (U.S.) Obesity Treatment Product Market Performance
10.19.4 Brunswick Corporation (U.S.) Business Overview
10.19.5 Brunswick Corporation (U.S.) Recent Developments
10.20 Technogym SpA (Italy)
10.20.1 Technogym SpA (Italy) Obesity Treatment Basic Information
10.20.2 Technogym SpA (Italy) Obesity Treatment Product Overview
10.20.3 Technogym SpA (Italy) Obesity Treatment Product Market Performance
10.20.4 Technogym SpA (Italy) Business Overview
10.20.5 Technogym SpA (Italy) Recent Developments
11 Obesity Treatment Market Forecast by Region
11.1 Global Obesity Treatment Market Size Forecast
11.2 Global Obesity Treatment Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Obesity Treatment Market Size Forecast by Country
11.2.3 Asia Pacific Obesity Treatment Market Size Forecast by Region
11.2.4 South America Obesity Treatment Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Obesity Treatment by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Obesity Treatment Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Obesity Treatment by Type (2025-2032)
12.1.2 Global Obesity Treatment Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Obesity Treatment by Type (2025-2032)
12.2 Global Obesity Treatment Market Forecast by Application (2025-2032)
12.2.1 Global Obesity Treatment Sales (K Units) Forecast by Application
12.2.2 Global Obesity Treatment Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Obesity Treatment Market Size Comparison by Region (M USD)
Table 5. Global Obesity Treatment Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Obesity Treatment Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Obesity Treatment Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Obesity Treatment Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Treatment as of 2022)
Table 10. Global Market Obesity Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Obesity Treatment Sales Sites and Area Served
Table 12. Manufacturers Obesity Treatment Product Type
Table 13. Global Obesity Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Obesity Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Obesity Treatment Market Challenges
Table 22. Global Obesity Treatment Sales by Type (K Units)
Table 23. Global Obesity Treatment Market Size by Type (M USD)
Table 24. Global Obesity Treatment Sales (K Units) by Type (2019-2025)
Table 25. Global Obesity Treatment Sales Market Share by Type (2019-2025)
Table 26. Global Obesity Treatment Market Size (M USD) by Type (2019-2025)
Table 27. Global Obesity Treatment Market Size Share by Type (2019-2025)
Table 28. Global Obesity Treatment Price (USD/Unit) by Type (2019-2025)
Table 29. Global Obesity Treatment Sales (K Units) by Application
Table 30. Global Obesity Treatment Market Size by Application
Table 31. Global Obesity Treatment Sales by Application (2019-2025) & (K Units)
Table 32. Global Obesity Treatment Sales Market Share by Application (2019-2025)
Table 33. Global Obesity Treatment Sales by Application (2019-2025) & (M USD)
Table 34. Global Obesity Treatment Market Share by Application (2019-2025)
Table 35. Global Obesity Treatment Sales Growth Rate by Application (2019-2025)
Table 36. Global Obesity Treatment Sales by Region (2019-2025) & (K Units)
Table 37. Global Obesity Treatment Sales Market Share by Region (2019-2025)
Table 38. North America Obesity Treatment Sales by Country (2019-2025) & (K Units)
Table 39. Europe Obesity Treatment Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Obesity Treatment Sales by Region (2019-2025) & (K Units)
Table 41. South America Obesity Treatment Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Obesity Treatment Sales by Region (2019-2025) & (K Units)
Table 43. Global Obesity Treatment Production (K Units) by Region (2019-2025)
Table 44. Global Obesity Treatment Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Obesity Treatment Revenue Market Share by Region (2019-2025)
Table 46. Global Obesity Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Obesity Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Obesity Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Obesity Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Obesity Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. NutriSystem Obesity Treatment Basic Information
Table 52. NutriSystem Obesity Treatment Product Overview
Table 53. NutriSystem Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. NutriSystem Business Overview
Table 55. NutriSystem Obesity Treatment SWOT Analysis
Table 56. NutriSystem Recent Developments
Table 57. Inc. (U.S.) Obesity Treatment Basic Information
Table 58. Inc. (U.S.) Obesity Treatment Product Overview
Table 59. Inc. (U.S.) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Inc. (U.S.) Business Overview
Table 61. Inc. (U.S.) Obesity Treatment SWOT Analysis
Table 62. Inc. (U.S.) Recent Developments
Table 63. Kellogg Company (U.S.) Obesity Treatment Basic Information
Table 64. Kellogg Company (U.S.) Obesity Treatment Product Overview
Table 65. Kellogg Company (U.S.) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Kellogg Company (U.S.) Obesity Treatment SWOT Analysis
Table 67. Kellogg Company (U.S.) Business Overview
Table 68. Kellogg Company (U.S.) Recent Developments
Table 69. Ethicon Obesity Treatment Basic Information
Table 70. Ethicon Obesity Treatment Product Overview
Table 71. Ethicon Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Ethicon Business Overview
Table 73. Ethicon Recent Developments
Table 74. Inc. (U.S.) Obesity Treatment Basic Information
Table 75. Inc. (U.S.) Obesity Treatment Product Overview
Table 76. Inc. (U.S.) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Inc. (U.S.) Business Overview
Table 78. Inc. (U.S.) Recent Developments
Table 79. Medtronic (U.S.) Obesity Treatment Basic Information
Table 80. Medtronic (U.S.) Obesity Treatment Product Overview
Table 81. Medtronic (U.S.) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Medtronic (U.S.) Business Overview
Table 83. Medtronic (U.S.) Recent Developments
Table 84. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Basic Information
Table 85. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product Overview
Table 86. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. F. Hoffmann-La Roche (Switzerland) Business Overview
Table 88. F. Hoffmann-La Roche (Switzerland) Recent Developments
Table 89. Atkins Nutritionals Obesity Treatment Basic Information
Table 90. Atkins Nutritionals Obesity Treatment Product Overview
Table 91. Atkins Nutritionals Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Atkins Nutritionals Business Overview
Table 93. Atkins Nutritionals Recent Developments
Table 94. Inc. (U.S.) Obesity Treatment Basic Information
Table 95. Inc. (U.S.) Obesity Treatment Product Overview
Table 96. Inc. (U.S.) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Inc. (U.S.) Business Overview
Table 98. Inc. (U.S.) Recent Developments
Table 99. Herbalife Ltd. (U.S.) Obesity Treatment Basic Information
Table 100. Herbalife Ltd. (U.S.) Obesity Treatment Product Overview
Table 101. Herbalife Ltd. (U.S.) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Herbalife Ltd. (U.S.) Business Overview
Table 103. Herbalife Ltd. (U.S.) Recent Developments
Table 104. Covidien plc (U.S.) Obesity Treatment Basic Information
Table 105. Covidien plc (U.S.) Obesity Treatment Product Overview
Table 106. Covidien plc (U.S.) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Covidien plc (U.S.) Business Overview
Table 108. Covidien plc (U.S.) Recent Developments
Table 109. Apollo Endosurgery (U.S.) Obesity Treatment Basic Information
Table 110. Apollo Endosurgery (U.S.) Obesity Treatment Product Overview
Table 111. Apollo Endosurgery (U.S.) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Apollo Endosurgery (U.S.) Business Overview
Table 113. Apollo Endosurgery (U.S.) Recent Developments
Table 114. Amer Sports (Finland) Obesity Treatment Basic Information
Table 115. Amer Sports (Finland) Obesity Treatment Product Overview
Table 116. Amer Sports (Finland) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. Amer Sports (Finland) Business Overview
Table 118. Amer Sports (Finland) Recent Developments
Table 119. Johnson Health Technology Obesity Treatment Basic Information
Table 120. Johnson Health Technology Obesity Treatment Product Overview
Table 121. Johnson Health Technology Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 122. Johnson Health Technology Business Overview
Table 123. Johnson Health Technology Recent Developments
Table 124. Ltd. (Taiwan) Obesity Treatment Basic Information
Table 125. Ltd. (Taiwan) Obesity Treatment Product Overview
Table 126. Ltd. (Taiwan) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 127. Ltd. (Taiwan) Business Overview
Table 128. Ltd. (Taiwan) Recent Developments
Table 129. Cybex International (U.S.) Obesity Treatment Basic Information
Table 130. Cybex International (U.S.) Obesity Treatment Product Overview
Table 131. Cybex International (U.S.) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 132. Cybex International (U.S.) Business Overview
Table 133. Cybex International (U.S.) Recent Developments
Table 134. USGI Medical (U.S.) Obesity Treatment Basic Information
Table 135. USGI Medical (U.S.) Obesity Treatment Product Overview
Table 136. USGI Medical (U.S.) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 137. USGI Medical (U.S.) Business Overview
Table 138. USGI Medical (U.S.) Recent Developments
Table 139. Olympus Corporation (Japan) Obesity Treatment Basic Information
Table 140. Olympus Corporation (Japan) Obesity Treatment Product Overview
Table 141. Olympus Corporation (Japan) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 142. Olympus Corporation (Japan) Business Overview
Table 143. Olympus Corporation (Japan) Recent Developments
Table 144. Brunswick Corporation (U.S.) Obesity Treatment Basic Information
Table 145. Brunswick Corporation (U.S.) Obesity Treatment Product Overview
Table 146. Brunswick Corporation (U.S.) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 147. Brunswick Corporation (U.S.) Business Overview
Table 148. Brunswick Corporation (U.S.) Recent Developments
Table 149. Technogym SpA (Italy) Obesity Treatment Basic Information
Table 150. Technogym SpA (Italy) Obesity Treatment Product Overview
Table 151. Technogym SpA (Italy) Obesity Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 152. Technogym SpA (Italy) Business Overview
Table 153. Technogym SpA (Italy) Recent Developments
Table 154. Global Obesity Treatment Sales Forecast by Region (2025-2032) & (K Units)
Table 155. Global Obesity Treatment Market Size Forecast by Region (2025-2032) & (M USD)
Table 156. North America Obesity Treatment Sales Forecast by Country (2025-2032) & (K Units)
Table 157. North America Obesity Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 158. Europe Obesity Treatment Sales Forecast by Country (2025-2032) & (K Units)
Table 159. Europe Obesity Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 160. Asia Pacific Obesity Treatment Sales Forecast by Region (2025-2032) & (K Units)
Table 161. Asia Pacific Obesity Treatment Market Size Forecast by Region (2025-2032) & (M USD)
Table 162. South America Obesity Treatment Sales Forecast by Country (2025-2032) & (K Units)
Table 163. South America Obesity Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 164. Middle East and Africa Obesity Treatment Consumption Forecast by Country (2025-2032) & (Units)
Table 165. Middle East and Africa Obesity Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 166. Global Obesity Treatment Sales Forecast by Type (2025-2032) & (K Units)
Table 167. Global Obesity Treatment Market Size Forecast by Type (2025-2032) & (M USD)
Table 168. Global Obesity Treatment Price Forecast by Type (2025-2032) & (USD/Unit)
Table 169. Global Obesity Treatment Sales (K Units) Forecast by Application (2025-2032)
Table 170. Global Obesity Treatment Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Obesity Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Obesity Treatment Market Size (M USD), 2019-2032
Figure 5. Global Obesity Treatment Market Size (M USD) (2019-2032)
Figure 6. Global Obesity Treatment Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Obesity Treatment Market Size by Country (M USD)
Figure 11. Obesity Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Obesity Treatment Revenue Share by Manufacturers in 2023
Figure 13. Obesity Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Obesity Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Obesity Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Obesity Treatment Market Share by Type
Figure 18. Sales Market Share of Obesity Treatment by Type (2019-2025)
Figure 19. Sales Market Share of Obesity Treatment by Type in 2023
Figure 20. Market Size Share of Obesity Treatment by Type (2019-2025)
Figure 21. Market Size Market Share of Obesity Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Obesity Treatment Market Share by Application
Figure 24. Global Obesity Treatment Sales Market Share by Application (2019-2025)
Figure 25. Global Obesity Treatment Sales Market Share by Application in 2023
Figure 26. Global Obesity Treatment Market Share by Application (2019-2025)
Figure 27. Global Obesity Treatment Market Share by Application in 2023
Figure 28. Global Obesity Treatment Sales Growth Rate by Application (2019-2025)
Figure 29. Global Obesity Treatment Sales Market Share by Region (2019-2025)
Figure 30. North America Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Obesity Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Obesity Treatment Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Obesity Treatment Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Obesity Treatment Sales Market Share by Country in 2023
Figure 37. Germany Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Obesity Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Obesity Treatment Sales Market Share by Region in 2023
Figure 44. China Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Obesity Treatment Sales and Growth Rate (K Units)
Figure 50. South America Obesity Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Obesity Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Obesity Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Obesity Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Obesity Treatment Production Market Share by Region (2019-2025)
Figure 62. North America Obesity Treatment Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Obesity Treatment Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Obesity Treatment Production (K Units) Growth Rate (2019-2025)
Figure 65. China Obesity Treatment Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Obesity Treatment Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Obesity Treatment Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Obesity Treatment Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Obesity Treatment Market Share Forecast by Type (2025-2032)
Figure 70. Global Obesity Treatment Sales Forecast by Application (2025-2032)
Figure 71. Global Obesity Treatment Market Share Forecast by Application (2025-2032)
